Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
Open Access
- 18 July 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 119 (7), 1623-1629
- https://doi.org/10.1002/ijc.22015
Abstract
Persistent infection with high‐risk human papillomavirus (HPV) is central to cervical carcinogenesis. Certain high‐risk types, such as HPV16, may be more persistent than other HPV types, and type‐specific HPV persistence may differ by HIV serostatus. This study evaluated the association between HPV type and clearance of HPV infections in 522 HIV‐seropositive and 279 HIV‐seronegative participants in the HIV Epidemiology Research Study (HERS, United States, 1993–2000). Type‐specific HPV infections were detected using MY09/MY11/HMB01‐based PCR and 26 HPV type‐specific probes. The estimated duration of type‐specific infections was measured from the first HPV‐positive visit to the first of two consecutive negative visits. Hazard ratios (HRs) and 95% confidence intervals (CIs) for HPV clearance were calculated using Cox models adjusted for study site and risk behavior (sexual or injection drugs). A total of 1,800 HPV infections were detected in 801 women with 4.4 years median follow‐up. HRs for clearance of HPV16 and related types versus low‐risk HPV types were 0.79 (95% CI: 0.64–0.97) in HIV‐positive women and 0.86 (95% CI: 0.59–1.27) in HIV‐negative women. HRs for HPV18 versus low‐risk types were 0.80 (95% CI: 0.56–1.16) and 0.57 (95% CI: 0.22–1.45) for HIV‐positive and ‐negative women, respectively. HPV types within the high‐risk category had low estimated clearance rates relative to low‐risk types, but HRs were not substantially modified by HIV serostatus.Keywords
This publication has 27 references indexed in Scilit:
- A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage TestsJNCI Journal of the National Cancer Institute, 2005
- Longitudinal Study of Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus (HIV)–Seropositive and At‐Risk HIV‐Seronegative WomenThe Journal of Infectious Diseases, 2003
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Incidence, Prevalence, and Clearance of Type‐Specific Human Papillomavirus Infections: The Young Women’s Health StudyThe Journal of Infectious Diseases, 2002
- A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV TypesThe Journal of Infectious Diseases, 2001
- Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical CancerNew England Journal of Medicine, 1999
- Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical DysplasiaJNCI Journal of the National Cancer Institute, 1995
- Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal WomenThe Journal of Infectious Diseases, 1994
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989